-
Something wrong with this record ?
Poskytnou účinky inhibitorů sodíko-glukózového kontransportéru 2 u pacientů s diabetem pohled na možné používání u pacientů s onemocněním ledvin bez diabetu?
Harindra Rajasekeran, David Z. Cherney, Julie A. Lovshin
Current Opinion in Nephrology and Hypertension (České vyd.).
2018 ;
12 (1) :
7-15.
Language Czech Country Czech Republic
Document type Review
Persistent link
https://www.medvik.cz/link/bmc18008846
- MeSH
- Renal Insufficiency, Chronic drug therapy metabolism physiopathology MeSH
- Diabetes Mellitus, Type 2 drug therapy MeSH
- Diabetic Nephropathies physiopathology MeSH
- Sodium-Glucose Transporter 2 Inhibitors MeSH
- Kidney Glomerulus physiopathology MeSH
- Hemodynamics drug effects MeSH
- Hypoglycemic Agents pharmacology therapeutic use MeSH
- Blood Glucose metabolism drug effects MeSH
- Blood Pressure MeSH
- Humans MeSH
- Natriuresis MeSH
- Kidney Tubules, Proximal physiopathology MeSH
- Sodium metabolism MeSH
- Sodium-Glucose Transporter 2 MeSH
- Check Tag
- Humans MeSH
- Publication type
- Review MeSH
Department of Medicine University Health Network University of Toronto Ontario Kanada
Division of Nephrology Department of Medicine University Health Network
Citace: Rajasekeran H. et al.: Do effects of sodium-glucose cotransporter-2 inhibitors in patients with diabetes give insight into potential use in non-diabetic kidney disease? Curr Opin Nephrol Hypertens. 2017 Sep;26(5):358-367
Bibliography, etc.Literatura
- 000
- 00000naa a2200000 a 4500
- 001
- bmc18008846
- 003
- CZ-PrNML
- 005
- 20181206092505.0
- 007
- ta
- 008
- 180322s2018 xr d f 000 0|cze||
- 009
- AR
- 040 __
- $a ABA008 $d ABA008 $e AACR2 $b cze
- 041 0_
- $a cze
- 044 __
- $a xr
- 100 1_
- $a Rajasekeran, Harindra $u Division of Nephrology, Department of Medicine, University Health Network; Department of Physiology; Department of Medicine, University Health Network, University of Toronto, Ontario, Kanada
- 245 10
- $a Poskytnou účinky inhibitorů sodíko-glukózového kontransportéru 2 u pacientů s diabetem pohled na možné používání u pacientů s onemocněním ledvin bez diabetu? / $c Harindra Rajasekeran, David Z. Cherney, Julie A. Lovshin
- 500 __
- $a Citace: Rajasekeran H. et al.: Do effects of sodium-glucose cotransporter-2 inhibitors in patients with diabetes give insight into potential use in non-diabetic kidney disease? Curr Opin Nephrol Hypertens. 2017 Sep;26(5):358-367
- 504 __
- $a Literatura
- 650 _2
- $a krevní tlak $7 D001794
- 650 _2
- $a krevní glukóza $x metabolismus $x účinky léků $7 D001786
- 650 _2
- $a diabetes mellitus 2. typu $x farmakoterapie $7 D003924
- 650 _2
- $a diabetické nefropatie $x patofyziologie $7 D003928
- 650 _2
- $a hemodynamika $x účinky léků $7 D006439
- 650 _2
- $a hypoglykemika $x farmakologie $x terapeutické užití $7 D007004
- 650 _2
- $a glomerulus $x patofyziologie $7 D007678
- 650 _2
- $a proximální tubuly ledvin $x patofyziologie $7 D007687
- 650 _2
- $a natriuréza $7 D009318
- 650 _2
- $a chronická renální insuficience $x farmakoterapie $x metabolismus $x patofyziologie $7 D051436
- 650 _2
- $a sodík $x metabolismus $7 D012964
- 650 _2
- $a transportér 2 pro sodík a glukózu $7 D051297
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a glifloziny $7 D000077203
- 655 _2
- $a přehledy $7 D016454
- 700 1_
- $a Cherney, David Z. $u Division of Nephrology, Department of Medicine, University Health Network; Department of Physiology; Department of Medicine, University Health Network, University of Toronto, Ontario, Kanada
- 700 1_
- $a Lovshin, Julie A. $u Division of Endocrinology and Metabolism, Department of Medicine, University Health Network, University of Toronto, Ontario, Kanada
- 773 0_
- $t Current opinion in nephrology and hypertension $x 1802-3827 $g Roč. 12, č. 1 (2018), s. 7-15 $w MED00156014
- 910 __
- $a ABA008 $b B 2490 $c 903 $y 4 $z 0
- 990 __
- $a 20180322133039 $b ABA008
- 991 __
- $a 20181206092621 $b ABA008
- 999 __
- $a ok $b bmc $g 1284509 $s 1005638
- BAS __
- $a 3
- BMC __
- $a 2018 $b 12 $c 1 $d 7-15 $i 1802-3827 $m Current Opinion in Nephrology and Hypertension (České vyd.) $n Curr. Opin. Nephrol. Hypertens. (Čes. vyd.) $x MED00156014
- LZP __
- $c NLK182 $d 20181206 $a NLK 2018-05/mk
